Evaluation of health status in epilepsy using the EQ-5D questionnaire: A prospective, observational, 6-month study of adjunctive therapy with antiepileptic drugs

Current Medical Research and Opinion

Volumn 21, Issue 5, 2005, Pages 733-739

  Selai, Caroline E ^a   Trimble, Michael R ^a   Price, Martin J ^b   Remak, Edit ^c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b Janssen Cilag Ltd   (United Kingdom)

^c MEDTAP International Inc   (United Kingdom)

Author keywords

Adjunctive; Anti epileptic drugs; Epilepsy; EQ 5D; Health status; Quality of life

Indexed keywords

ANTICONVULSIVE AGENT; CLOBAZAM; GABAPENTIN; LAMOTRIGINE; TOPIRAMATE; VIGABATRIN;

ADULT; ARTICLE; EPILEPSY; EVALUATION; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PROSPECTIVE STUDY; QUESTIONNAIRE; SEIZURE; UNITED KINGDOM;

ADULT; AMINES; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; EPILEPSY; FEMALE; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECURRENCE; SICKNESS IMPACT PROFILE; TRIAZINES; VIGABATRIN;

EID: 18844424926     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X43695     Document Type: Article

References (11)

1. Baker GA, Jacoby A, Buck D, et al. Quality of life of people with epilepsy: A European study. Epilepsia 1997;38:353-62
2. Kline Leidy N, Rentz AM, Grace EM. Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy. Epilepsia 1998;39:965-77
3. Selai CE, Smith K, Trimble MR. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs. Seizure, 1999;8:8-13
4. Selai CE, Elstner K, Trimble MR. Is the EQ-5D sensitive to clinically defined treatment outcome in epilepsy? In Greiner W, v.d. Schulenburg J-M, Piercy J, editors. EuroQol, Plenary Meeting 1st-2nd October 1998; Discussion Papers, Centre of Health Economics and Health Systems Research, University of Hannover, 1999
5. Kaiser S, Selai CE, Trimble MR. Long-term follow-up of topiramate and lamotrigine: a perspective on quality of life. Seizure 2002;11:356-60
6. Kind P, Dolan P, Gudex C, et al. Variations in population health states: results from a United Kingdom national questionnaire survey. BMJ 1998;316:736-41
7. Stavem K, Bjørnæs H, Lossius MI. Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy. Epilepsy Res 2001;44:179-89
8. EuroQol Group. EuroQol EQ-5D user guide, 1996
9. Jacoby A, Baker GA, Steen N, et al. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia 1996;37:148-61
10. Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993;2:169-80
11. Remak E, Hutton J, Peeters K, et al. Estimated impact of seizure frequency on survival in epilepsy. Poster presentation, Assoc Br Neurol, Cardiff, United Kingdom, April 2003